GE Healthcare today announced the signing of a definitive merger agreement to acquire medical products provider Vital Signs Inc., of Totowa, N.J.
Under terms of the agreement, shareholders of Vital Signs will receive $74.50 per share in cash for each Vital Signs share they own. The company will become part of GE Healthcare’s Clinical Systems business, a provider of advanced technologies for patient monitoring, anesthesia delivery and acute respiratory care.
The transaction is subject to Vital Signs’ shareholder and regulatory approvals, as well as other customary conditions. It is expected to close in the fourth quarter of this year. The Boards of Directors of GE and Vital Signs have approved the transaction.
The deal values Vital Signs at approximately $860 million, net of Vital Signs cash and investments as of March 31.
Spanning from anesthesia to respiratory, sleep therapy to emergency medicine, Vital Signs has a broad offering of single-patient use products.
